Search company, investor...
VWR International company logo

VWR International

Founded Year



Take Private | Alive





About VWR International

VWR International is a global provider of products, services, and solutions to laboratory and production facilities for customers in the pharmaceutical, biotechnology, industrial, education, government, and healthcare industries. VWR offers a distribution network that reaches specialized labs and facilities spanning the globe. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration, and technical services.

Headquarters Location

6201 15th Avenue

Brooklyn, New York, 11219,

United States


Missing: VWR International's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: VWR International's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest VWR International News

Cell Culture Market Size to Worth Around US$ 52.65 Bn by 2030

Jun 21, 2022

Key Players Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC , Thermo Fisher Scientific Inc., VWR International LLC , Lonza, Eppendorf AG, FUJIFILM Irvine Scientific, Inc. Ask here for more customization study@ Regional Snapshot North America was the leading cell culture market in 2021. The outbreak of COVID-19 diseases and its rapid spread across the globe has attracted huge investments in the research studies that exponentially contributed to the growth of the cell culture market. Moreover, the North America region is the home to several top biopharmaceutical companies and several contract manufacturing and research organizations that spurs the demand for the cell culture techniques exponentially. The various government policies in US supports the medical research activities as the healthcare is one of the major industries in US. Healthcare expenditure accounted for around 18% of the US GDP in 2018.In 2016, The Human Cancer Models Initiative was undertaken to grow 1,000 new cell line for scientific studies within a period of three years. The favorable government support in medical research studies has significantly fostered the growth of the North America cell culture market. Asia Pacific is estimated to be the most opportunistic market during the forecast period. The presence of several top research institutes and contract research organizations significantly boosts the demand for the cell culture consumables. The rising demand for the development of various new and innovative drugs and vaccines is bolstering the growth of the Asia Pacific cell culture market. Market Dynamics Surging awareness regarding the advantages of cell-based vaccines Climate change, rising global population, and rising contact between animals and human has increased the risks of outbreaks of new viruses. Influenza, Swine Flu, and COVID-19 are some examples. This is a major factor that is boosting the need for cell based medical research studies to develop cell based vaccines to treat the various viruses and infections. Previously, the cell culture techniques has helped in the development of vaccines for various diseases such as smallpox, polio, rotavirus, hepatitis, and chickenpox. Therefore, the rising awareness regarding the benefits of cell based vaccines is expected to drive the growth of the cell culture market. Restraint High costs involved in cell biology research The cell biology involves research and development on new therapies like gene therapies and stem cell therapies. A high capital investment is required in the acquisition of various equipment and consumables that facilitates cell based biology research. Moreover, maintaining quality of the research studies and compliances to the regulatory guidelines has fueled the costs involved. Thus the high costs is a major restraining factor in the cell culture market. Opportunity Surging demand for the 3D cell culture The various advantages of the 3D cell culture over the 2D cell culture is boosting the demand for the 3D cell culture techniques. The greater stability and extended life spans of the 3D cell cultures over the 2D counterpart has boosted the adoption of the 3D cell culture across the globe. The rising adoption of the 3D cell culture is expected to drive the market growth in the foreseeable future. Related Reports Immediate Delivery Available | Buy this Premium Research Report@ You can place an order or ask any questions, please feel free to contact at   | +1 9197 992 333 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us:

VWR International Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

VWR International Rank

VWR International Frequently Asked Questions (FAQ)

  • When was VWR International founded?

    VWR International was founded in 1986.

  • Where is VWR International's headquarters?

    VWR International's headquarters is located at 6201 15th Avenue, Brooklyn.

  • What is VWR International's latest funding round?

    VWR International's latest funding round is Take Private.

  • Who are the investors of VWR International?

    Investors of VWR International include Avantor and Madison Dearborn Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.